DCF Advisers, LLC
Long book
$265.3M
Q1 2026
Positions
72
Top-10 weight
50%
concentration
Last quarter
+51.4%
SPY +14.8%
Turnover
16%
of book per quarter
Strategy in plain words
auto-generated from filingsDCF Advisers, LLC is a diversified fundamental manager, running a $265.3M US long book across 72 positions.
The portfolio is concentrated: the top 10 names carry 50% of the portfolio. Turnover is modest: positions are typically held for years. Current anchor positions: MICRON TECHNOLOGY INC, ALPHABET INC-CL C, ARGENX SE - ADR, CORVUS PHARMACEUTICALS INC, TEVA PHARMACEUTICAL-SP ADR.
Over the last 9 quarters its long book ran on average 7.2pp per quarter ahead of the S&P 500, beating the index in 5 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+3.9%
Q2 2024
+3.9%
Q3 2024
-0.7%
Q4 2024
-3.2%
Q1 2025
+9.7%
Q2 2025
+20.7%
Q3 2025
+20.5%
Q4 2025
-1.3%
Q1 2026
+51.4%
Sector allocation
Technology 50%
Healthcare 31%
Financials 6%
Consumer discretionary 5%
Utilities 3%
Services media 3%
Industrials 2%
Other 0%
Long book by quarter
What does DCF Advisers, own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| MU MICRON TECHNOLOGY INC | Technology | 150.0K | $50.7M | 19.1% | -10.3% |
| GOOG ALPHABET INC-CL C | Technology | 57.0K | $16.4M | 6.2% | Held |
| CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 637.5K | $9.3M | 3.5% | -12.6% |
| AMZN AMAZON.COM INC | Consumer discretionary | 38.0K | $7.9M | 3.0% | +18.8% |
| LLY ELI LILLY & CO | Healthcare | 8.3K | $7.6M | 2.9% | Held |
| REGN REGENERON PHARMACEUTICALS | Healthcare | 9.3K | $7.1M | 2.7% | -7.5% |
| AMD ADVANCED MICRO DEVICES | Technology | 29.0K | $5.9M | 2.2% | -3.3% |
| BAC BANK OF AMERICA CORP | Financials | 119.5K | $5.8M | 2.2% | Held |
| ET ENERGY TRANSFER LP | Utilities | 300.5K | $5.8M | 2.2% | Held |
| NAMS NEWAMSTERDAM PHARMA CO NV | Healthcare | 160.6K | $5.1M | 1.9% | Held |
| CSCO CISCO SYSTEMS INC | Technology | 55.0K | $4.3M | 1.6% | +10.0% |
| IONS IONIS PHARMACEUTICALS INC | Healthcare | 56.0K | $4.2M | 1.6% | -45.6% |
| ORCL ORACLE CORP | Technology | 28.5K | $4.2M | 1.6% | Held |
| C CITIGROUP INC | Financials | 36.0K | $4.1M | 1.5% | Held |
| UBER UBER TECHNOLOGIES INC | Services media | 55.0K | $4.0M | 1.5% | Held |
| INCY INCYTE CORP | Healthcare | 41.5K | $3.9M | 1.5% | Held |
| ZM ZOOM COMMUNICATIONS INC | Technology | 46.5K | $3.7M | 1.4% | +53.7% |
| HELP CYBIN INC | Healthcare | 692.0K | $3.3M | 1.3% | -10.8% |
| VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 7.0K | $3.1M | 1.2% | +16.7% |
| ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 30.5K | $2.8M | 1.0% | Held |
| MRVL MARVELL TECHNOLOGY INC | Technology | 27.5K | $2.7M | 1.0% | Held |
| ABX BARRICK GOLD CORP | Financials | 60.0K | $2.4M | 0.9% | Held |
| ABBV ABBVIE INC | Healthcare | 10.8K | $2.3M | 0.9% | Held |
| AMGN AMGEN INC | Healthcare | 6.0K | $2.1M | 0.8% | -55.6% |
| BNED BARNES & NOBLE EDUCATION INC | Consumer discretionary | 196.9K | $1.7M | 0.7% | -8.4% |
| LRCX LAM RESEARCH CORP | Industrials | 7.5K | $1.6M | 0.6% | Held |
| LFCR LIFECORE BIOMEDICAL INC | Healthcare | 424.5K | $1.6M | 0.6% | -4.0% |
| INTC INTEL CORP | Technology | 35.0K | $1.5M | 0.6% | -12.5% |
| AVGO BROADCOM INC | Technology | 4.9K | $1.5M | 0.6% | +8.3% |
| AAPL APPLE INC | Technology | 5.8K | $1.5M | 0.6% | -37.8% |
| LYFT LYFT INC-A | Services media | 102.5K | $1.4M | 0.5% | -31.7% |
| QCOM QUALCOMM INC | Technology | 10.3K | $1.3M | 0.5% | Held |
| XNCR XENCOR INC | Healthcare | 103.7K | $1.3M | 0.5% | -33.0% |
| META META PLATFORMS INC-CLASS A | Technology | 2.0K | $1.1M | 0.4% | Held |
| BHVN BIOHAVEN LTD | Healthcare | 123.5K | $1.0M | 0.4% | -18.5% |
| ALLT ALLOT LTD | Technology | 156.5K | $1.0M | 0.4% | +117.4% |
| ANAB ANAPTYSBIO INC | Healthcare | 18.8K | $1.0M | 0.4% | -46.7% |
| GM GENERAL MOTORS CO | Industrials | 12.5K | $931K | 0.4% | Held |
| ARQ ARQ INC | Other | 327.8K | $839K | 0.3% | +25.8% |
| QURE UNIQURE NV | Healthcare | 49.0K | $801K | 0.3% | New |
| IMRX IMMUNEERING CORP - CLASS A | Healthcare | 141.5K | $746K | 0.3% | -34.2% |
| PRTA PROTHENA CORP PLC | Healthcare | 73.2K | $712K | 0.3% | -62.6% |
| LNSR LENSAR INC | Healthcare | 118.2K | $705K | 0.3% | Held |
| OI O-I GLASS INC | Industrials | 60.0K | $631K | 0.2% | -7.3% |
| VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 32.1K | $629K | 0.2% | -39.0% |
| TPB TURNING POINT BRANDS INC | Consumer staples | 7.0K | $608K | 0.2% | Held |
| SPOT SPOTIFY TECHNOLOGY SA | Communications | 1.3K | $606K | 0.2% | Held |
| MSFT MICROSOFT CORP | Technology | 1.5K | $555K | 0.2% | New |
| SNPS SYNOPSYS INC | Technology | 1.3K | $496K | 0.2% | New |
| PINS PINTEREST INC- CLASS A | Technology | 25.0K | $459K | 0.2% | New |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 11, 2026 | 86 | $375.1M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 11, 2026 | 95 | $372.8M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 12, 2025 | 95 | $311.2M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 12, 2025 | 84 | $215.8M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 9, 2025 | 86 | $208.9M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 11, 2025 | 87 | $206.7M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 13, 2024 | 97 | $250.2M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 12, 2024 | 94 | $194.1M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 83 | $203.0M | canonical | SEC ↗ |
Similar funds
DIAMANT ASSET MANAGEMENT, INC. LILLY ENDOWMENT INCBROOKFIELD Corp /ON/GQG Partners LLCMITSUBISHI UFJ FINANCIAL GROUP INCNewport Trust Company, LLCVIKING GLOBAL INVESTORS LPPARNASSUS INVESTMENTS, LLC MASTERCARD FOUNDATION ASSET MANAGEMENT CORPPZENA INVESTMENT MANAGEMENT LLCCOATUE MANAGEMENT LLCWinslow Capital Management, LLC